Mortality in a cohort of HIV-infected adults started on a protease inhibitor-containing therapy: Standardization to the general population

Journal of Acquired Immune Deficiency Syndromes

Volumn 26, Issue 5, 2001, Pages 480-482

  Lewden, Charlotte ^a   Raffi, François ^b   Chêne, Geneviève ^a   Sobel, Alain ^c   Leport, Catherine ^d  

^a INSERM   (France)

^b Maladies Infectieuses et Tropicales   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d Faculté Xavier Bichat   (France)

Author keywords

HAART; HIV 1 infection; Mortality; Protease inhibitors; Standardization

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STANDARDIZATION; TREATMENT FAILURE;

EID: 0035870617     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200104150-00013     Document Type: Article

References (6)

1. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352: 1725-30.
2. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-60.
3. Institut National de la Santé et de la Recherche Médicale. SC8 Service d'information sur les causes de décès. Available at: http://sc8.vesinet.inserm.fr:1080/
4. Breslow N, Day N. Statistical methods in cancer research II. The design and analysis of cohort studies. Lyon: WHO-International Agency for Research on Cancer, 1987.
5. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, et al. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA 1994;272: 1915-21.
6. von Overbeck J, Egger M, Smith GD, Schoep M, Ledergerber B, Furrer H, et al. Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study. AIDS 1994;8: 1307-13.